Skip to main content
. 2022 Jan 24;327(6):546–558. doi: 10.1001/jama.2022.0028

Table 1. Baseline Characteristics of the Participants.

Continuous positive airway pressure
(n = 380)
High-flow nasal oxygen
(n = 418)
Conventional oxygen therapy
(n = 475)
Treatment period, No. (%)
Before July 2020 47 (12.4) 44 (10.5) 47 (9.9)
July 2020-January 2021 262 (69.0) 289 (69.1) 331 (69.7)
After January 2021 71 (18.7) 85 (20.3) 97 (20.4)
Age, mean (SD), y 56.7 (12.5) 57.6 (13.0) 57.6 (12.7)
Sex, No. (%)
Male 260 (68.4) 272 (65.1) 312 (65.7)
Female 120 (31.6) 146 (34.9) 163 (34.3)
Race and ethnicity, No. (%)a
Asianb 73 (19.2) 77 (18.4) 90 (18.9)
Blackc 16 (4.2) 14 (3.3) 19 (4.0)
Multipled 3 (0.8) 4 (1.0) 6 (1.3)
Whitee 243 (63.9) 276 (66.0) 312 (65.7)
Otherf 11 (2.9) 12 (2.9) 9 (1.9)
Not given 33 (8.7) 34 (8.1) 35 (7.4)
Time from symptom onset, median (IQR), d
To hospital admission (n = 376); 7.0 (5.5-10.0) (n = 407); 8.0 (5.0-10.0) (n = 466); 7.0 (5.0-10.0)
To randomization (n = 378); 9.0 (7.0-12.0) (n = 414); 9.0 (7.0-12.0) (n = 470); 9.0 (6.0-12.0)
COVID-19 status, No. (%) (n = 379) (n = 417) (n = 473)
Confirmed 326 (85.8) 355 (84.9) 409 (86.1)
Suspected 53 (13.9) 62 (14.8) 64 (13.5)
Comorbidities, No. (%)
Other (none of the below) 148 (38.9) 141 (33.7) 188 (39.6)
Hypertension 131 (34.5) 164 (39.2) 153 (32.2)
Diabetes requiring medication 86 (22.6) 98 (23.4) 91 (19.2)
Morbid obesity (body mass index >35)g 62 (16.3) 81 (19.4) 75 (15.8)
Chronic lung disease 65 (17.1) 52 (12.4) 66 (13.9)
Coronary heart disease 34 (8.9) 26 (6.2) 44 (9.3)
Uncontrolled or active malignancy 7 (1.8) 10 (2.4) 7 (1.5)
Dementia 4 (1.1) 1 (0.2) 3 (0.6)
End-stage kidney disease requiring kidney replacement therapy 2 (0.5) 6 (1.4) 5 (1.1)
Congestive heart failure 2 (0.5) 4 (1.0) 5 (1.1)
Clinical Frailty Scale, No. (%)h
Very fit to managing welli 351 (92.4) 376 (90.0) 430 (90.5)
Very mild frailty to terminally illj 19 (5.0) 35 (8.4) 39 (8.2)
Respiratory rate, median (IQR), /min (n = 377); 24 (21-30) (n = 414); 24 (20-29) (n = 472); 23 (20-28)
Fio2, median (IQR) (n = 363); 0.60 (0.40-0.80) (n = 404); 0.60 (0.40-0.80) (n = 459); 0.60 (0.40-0.80)
Spo2, median (IQR), % (n = 378); 94.0 (92.0-95.0) (n = 409); 93.0 (91.0-95.0) (n = 470); 94.0 (92.0-95.0)
Ratio of Spo2 to Fio2, median (IQR), % (n = 363); 155.0 (110.6-232.5) (n = 399); 156.7 (113.8-232.5) (n = 457); 156.7 (115.0-230.0)
Pao2, median (IQR), mm Hg (n = 238); 67.5 (60.0-77.3) (n = 287); 66.0 (59.3-74.3) (n = 317); 66.8 (58.5-80.3)
Ratio of Pao2 to Fio2, median (IQR), mm Hg (n = 229); 112.5 (80.0-161.3) (n = 284); 115.0 (80.9-168.4) (n = 308); 113.8 (84.8-150.9)
Paco2, median (IQR), mm Hg (n = 252); 33.0 (30.0-36.8) (n = 306); 33.0 (30.0-36.0) (n = 331); 33.8 (30.8-36.8)

Abbreviations: Fio2, fraction of inspired oxygen; Spo2, oxygen saturation as measured by pulse oximetry.

a

Categories were based on the NHS Data Model and Dictionary.

b

Asian-Indian, Asian-Pakistani, Asian-Bangladeshi, multiple-White and Asian, or any other Asian background.

c

Black/African/Caribbean/Black British-African, Black/African/Caribbean/Black British-Caribbean, Black/African/Caribbean/Black British, or any other Black/African/Caribbean/Black British background.

d

Any other multiple racial and ethnic combination.

e

White British, White Irish, multiple-White and Black Caribbean, multiple-White and Black African, or any other White background.

f

Chinese or any other racial and ethnic combination not listed in footnotes b through e.

g

Body mass index is calculated as weight in kilograms divided by height in meters squared.

h

Based on functional status prior to hospital admission and determined through chart review or patient assessment. It is measured on a 9-point scale (very fit to terminally ill) with lower scores indicating better functional status and a lower level of frailty.

i

Categories correspond to scores of 1 to 3.

j

Categories correspond to scores of 4 to 9.